FDA Announces Recall of Pet Food Sold in 10 States
The U.S. Food and Drug Administration (FDA) announced the recall of a pet food sold in 10 states on Tuesday.Concerns...
FDA
FDA Approves Expanded Indications for GE HealthCare’s Vizamyl PET Imaging Agent for Beta Amyloid Detection, Enabling More Precise Care for Alzheimer’s Patients
PET brain scan using Vizamyl (flutemetamol F18) with quantification software The FDA has approved an updated label for Vizamyl (flutemetamol...
FDA broadens reach of GE HealthCare’s amyloid imaging agent Vizamyl in Alzheimer’s diagnostics
The FDA expanded the uses of GE HealthCare’s Vizamyl imaging agent for highlighting the presence of beta amyloid proteins in...
FDA Approves Expanded Indications for GE HealthCare’s Vizamyl PET Imaging Agent for Beta Amyloid Detection, Enabling More Precise Care for Alzheimer’s Patients |
ARLINGTON HEIGHTS, Ill.--(BUSINESS WIRE)--Jun 24, 2025--GE HealthCare (Nasdaq: GEHC) today announced that the U.S. Food and Drug Administration (FDA) has...
FDA Approves Expanded Indications for GE HealthCare’s Vizamyl PET Imaging Agent for Beta Amyloid Detection, Enabling More Precise Care for Alzheimer’s Patients
FDA Approves Expanded Indications for GE HealthCare’s Vizamyl PET Imaging Agent for Beta Amyloid Detection, Enabling More Precise Care for...
GE HealthCare Stock Likely to Rise After FDA Approval of Flyrcado
GE HealthCare Technologies, Inc. GEHC announced that it has received FDA approval for Flyrcado (flurpiridaz F 18), a breakthrough positron...
GE Healthcare gets FDA nod for new PET imaging agent
Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief:...
GE HealthCare announces FDA approval of Flyrcado (flurpiridaz F 18) injection PET radiotracer for enhanced diagnosis of coronary artery disease
GE HealthCare’s FDA-approved flurpiridaz F 18 PET radiotracer, Flyrcado, delivers higher diagnostic efficacy in patients with known or suspected coronary...
FDA approves GE HealthCare’s flurpiridaz F-18 PET radiotracer for CAD
The U.S. Food and Drug Administration (FDA) has granted a long-awaited approval to flurpiridaz F-18, GE HealthCare's first-of-its-kind positron emission...
